Specialty Vaccine Company PaxVax, Inc. To Present At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum

PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced that company Chief Executive Officer Ken Kelley will be presenting at the 13th Annual BIO Investor Forum. Hosted by the Biotechnology Industry Organization (BIO), the Investor Forum features presentations from leading private and emerging public companies. The meeting will take place October 7-8, 2014 at the Palace Hotel in San Francisco, California.

Help employers find you! Check out all the jobs and post your resume.

Back to news